VEGFA and retinal disorder: Leakage during retinopathies is driven by permeability-inducing factors (PIFs), most prominently by the angiogenic growth factor VEGF-A, and VEGF-A antagonists are successfully used to reduce oedema and abnormal vessel growth, and to restore neuronal dysfunction (Brown et al., 2013).